期刊文献+

以霍乱毒素重组B亚单位为佐剂的流感抗原滴鼻免疫效果研究 被引量:3

Intranasal Administration of Trivalent Influenza Virus with rCTB on Mice
下载PDF
导出
摘要 研究霍乱毒素重组B亚单位(recombinant cholera toxin B subunit,rCTB)为佐剂的流感抗原滴鼻免疫小鼠后,小鼠的体液免疫和局部黏膜免疫反应。三价流感病毒灭活抗原及裂解抗原按比例与rCTB配伍,滴鼻免疫小鼠,分析血清中IgG和IgM的动态变化,二免三周后,分析血清中HAI的变化,收集鼻、肺冲洗液,分析IgG和sIgA的变化。结果表明:全病毒组及rCTB+裂解抗原组各项指标变化较明显,小鼠血清IgG和IgM在二免三周后仍维持在较高的水平,而其他两组均呈下降趋势;全病毒组鼻、肺冲洗液IgG和sIgA抗体滴度以及血清HAI抗体滴度均高于rCTB+全病毒组(P<0.01),而rCTB+裂解抗原组鼻、肺冲洗液IgG和sIgA抗体滴度以及血清HAI抗体滴度明显高于裂解抗原组(P<0.01)。研究表明:以全病毒抗原及rCTB+裂解抗原滴鼻免疫小鼠,均可诱导小鼠产生较强的系统免疫反应和局部黏膜免疫反应。rCTB与流感裂解抗原配伍滴鼻,可提高抗原的免疫原性,增强机体的黏膜免疫应答反应。 To study the systemic and mucosal antibody response induced by i. n. trivalent whole influenza virus (wFlu) and trivalent split influenza virus (sFlu) with rCTB. wFlu and sFlu was formulated with rCTB, administered intranasal (i. n. ). Mice sera were collected from 0 day to 28 day post i. n. Changes of serum IgG and IgM were observed, as well as the titres of hemagglutination inhibition (HAI) and specific IgG and sIgA in lung and nasal washes were determined. The result showed that the mice i.n. with rCTB-wFlu and rCTB-sFlu changed obviously. In brief, the wFlu and rCTB-sFlu elicited high titres of serum IgG, and IgM and maintained high level post 28d, whereas the others decreased post 28d. In addition, i.n. with wFlu induced significant higher titres of HAI and specific IgG and sIgA in lung and nasal washes than rCTB-wFlu, but the rCTB-sFlu induced significant higher titres of HAI and specific IgG and sIgA in lung and nasal washes than sFlu. I.n. with wFlu or rCTB sFlu might elicit systemic and mucosal immunoresponse. And rCTB are a potent mucosal adjuvants for split influenza vaccines.
出处 《西北农业学报》 CAS CSCD 北大核心 2007年第4期202-205,共4页 Acta Agriculturae Boreali-occidentalis Sinica
基金 军事医学科学院微生物流行病研究所免疫学实验室与华兰生物工程股份有限公司合作项目(56081)
关键词 流感 rCTB 免疫效果 Influenza rCTB Immunoresponse
  • 相关文献

参考文献9

  • 1何维明,高玉鹏,姜艳芬,黄建文,刘斌峰,潘瑞.禽流感流行病学调查及病原分离鉴定初报[J].西北农业学报,2001,10(3):16-19. 被引量:15
  • 2Carolyn B,Bridges M D.Center for Disease Control and Prevention Control of Influenza:Recommendations of the advisory committee on immunization(ACIP)[J].MMWR,2005,51:1-23.
  • 3Keitel W A,Pieda P A.Live Cold-adapted,Reassortant Influenza vaccine[M].In:Nicholson KG,Webster RG,Hay A J,editors.Textbook of Influenza.Oxford:Blackwell Science,1998.373-990.
  • 4Evgenia G,Dan E,Reuven L,et al.Mucosal(SIgA)and serum(IgG)immunologic responses in young adults following intranasal administration of one or two doses of inactivated,trivalent anti-influenza vaccine[J].Vaccine,2004,22(20):2566-2577.
  • 5Takada A,Kuboki N,Okazaki K,et al.Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic[J].Virol,1999,73(10):8303-8307.
  • 6Pizza M,Giuliani M,Fontana M,et al.Mucosal vaccines:nontoxic derivatives of LT and CT as mucosal adjuvants[J].Vaccine,2001,19(11):2534-2541.
  • 7Holmgren J,Harandi A M,Czerkinsky C,et al.Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin,cholera toxin B subunit and CpG DNA[J].Expert Rev Vaccines,2005,97(2):205-217.
  • 8吴秀芳,于三科,谢应国,王栋,袁源,刑丽,武素琴,王希良.鼠疫F1-V重组蛋白疫苗滴鼻免疫应答效果的研究[J].免疫学杂志,2006,22(3):269-272. 被引量:6
  • 9Kunio T,Masanori I,Yoko Y,et al.Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin[J].Vaccine,1998,16(2):150-155.

二级参考文献13

  • 1黄顺军,王希良,李名扬,罗德炎,阳幼荣,马丽娟.鼠疫F1-V融合蛋白在大肠杆菌中的高效表达及鉴定[J].免疫学杂志,2004,20(z1):152-155. 被引量:10
  • 2牛廷献,刘明远,卢强,付宝权,Pascal Boireau.旋毛虫新生幼虫T668重组抗原对小鼠的保护性免疫[J].免疫学杂志,2005,21(1):20-22. 被引量:9
  • 3陈伯伦,张泽纪,陈伟斌.禽流感研究I.鸡A型禽流感病毒的分离与血清学初步鉴定[J].中国兽医杂志,1994,20(10):3-5. 被引量:240
  • 4Titball RW, Williamson ED. Vaccination against bubonic and pneumonic Plague [ J ]. Vaccine, 2001, 19 (30) : 4 175 - 4 184.
  • 5Eyles JE, Williamson ED, Spiers ID, et al. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits[ J ].J Control Release,2000,63(1/2) : 191 - 200.
  • 6Fan E, O'Neal CJ, Mitchell DD, et al. Structural biology and structure-based inhibitor design of cholera toxin and heatlabile enterotoxin[J]. Int J Med Microbiol, 2004 ,294(4):217 - 223.
  • 7Xu Amano J, Kiyono H, Jackson R J, et al. Helper T cell subsets for IgA responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucasa associated tissues [ J ]. J Exp Med, 1993,178 (4): 1 309- 1 320.
  • 8Kagnoff ME . Mucosal immunology : new frontiers [ J ] . Immunol Today, 1996, 17(2): 57-59.
  • 9Glyun A, Freytag LC, Clements JD. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens[J]. Vaccine, 2005, 23(16):1 957- 1 965.
  • 10Plante M, Jones T, Allard F, et al. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI,mucosal IgA and protection against influenza challenge [ J ].Vaccine, 2001, 20 (1/2) : 218 - 225.

共引文献19

同被引文献20

  • 1林厚怡,宋兰珍,佘雪轩.离子交换柱层析分离霍乱类毒素[J].南京医科大学学报(自然科学版),1994,14(3):304-306. 被引量:1
  • 2高玲,张大兵,欧阳凤秀,姜庆五.霍乱毒素B亚单位胰岛素混合蛋白抗糖尿病作用[J].中国公共卫生,2006,22(10):1245-1246. 被引量:1
  • 3Schulze K, Medina E, Talay SR, et al. Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response. Infect Immun, 2001, 69(1): 622-5
  • 4Pizza M, Giuliani M, Fontana M, et al. Mucosal vaccines: nontoxic derivatives of L T and CT as mucosal adjuvants. Vaccine, 2001, 19(17-19): 2534-41
  • 5Sun JB, Raghavan S, Sjoling A, et al. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3^+ CD25^+ and Foxp3- CD25^- CD4^+ regulatory T cells. J Immunol, 2006, 177(11): 7634-44
  • 6Tamura S, Funato H, Hirabayashi Y, et al. Functional role of respiratory tractheamaglutin-spectific IgA antibodies in protection against influenza. Vaccine, 1990, 8(5): 479-85
  • 7Luci C, Hervouet C, Rousseau D, et al. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol, 2006, 176(5): 2749-57
  • 8Coccia EM, Remoli ME, Giacinto CD. Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn's disease. Gut, 2005, 54: 1558-64
  • 9Isaka M, Komiya T, Takahashi M, et al. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine. Vaccine, 2004, 22 (23-24): 3061-8
  • 10Holmgren J, Adamsson J, Clemens, J, et al. Mucosal adjuvants and antiinfection and antiimmunopat-hology vaccines based on cholera toxin, cholera toxin B subunit and Cp G DNA. Immunol Lett, 2005, 97(2): 181-8

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部